Neith Corporation

NT$15.00As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6236Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (3.07%)
Div yield —
ROE 0.21%
Biotechnology
Beta (5Y) (0.10)
PE TTM 1,929
TSR TTM (47.37%)
Mkt cap NT$624.8M
ROIC (0.84%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$17
12.31%
(92.96%)
Hold 12|10|12|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.14
0.14
0.14
0.14
13.64%
7.46%
2.86%
(1.35%)
RevenueNT$M
59.08
59.83
63.28
63.20
(2.43%)
1.58%
5.64%
7.05%
Peers (US$18.87M)
Cap (US$)
PE
18.21M
38.63x
Capital
TTM
5Y
10Y
Leveragex
2.177
0.013
0.014
EBIT/Intx
5.306
0.061
0.064
Own earn%
37.75
215.20
197.83
Sh yield%
24.35
33.00
26.91
Owners
Insiders/Inst%
7.83
59.25
Short interest%
5.81
SBC / revenue%
0.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
10–23
$1 testx
—
Incr. ROIC%
4